Antihistamines and allergy pills and psilocybin.
20 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as antihistamine · allergy pill · allergy medicine · allergy medication
01 What the evidence covers
Best evidence available per medication| 20 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZOccasional headaches and minor aches and pains with accompanying sleeplessness
It causes drowsiness and may cause confusion with psilocybin. The acetaminophen part has no known psilocybin interaction.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Seasonal allergies (seasonal allergic rhinitis); Non-allergic runny nose (vasomotor rhinitis)
Not studied with psilocybin; its sleepiness may add to other sedating effects. Also, its label warns against combining it with alcohol or sedatives.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Seasonal allergic rhinitis (ages 6 and older)
Not studied with psilocybin; its sleepiness may add to other sedating effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Cough and upper respiratory symptoms, including nasal congestion, from allergies or the common cold
Its ingredients act on serotonin, raise blood pressure and heart rate, and cause sedation; each may add to psilocybin's effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Hay fever and upper respiratory allergy symptoms (runny nose, sneezing, itchy watery eyes); Hives (urticaria) and itching from hives
Not studied with psilocybin; no linking mechanism is described. Also, it can cause dose-related sleepiness.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Allergic and nonallergic nasal symptoms (allergic and vasomotor rhinitis); Allergic eye inflammation (allergic conjunctivitis)
It blocks the receptor psilocybin works through, so it is expected to weaken psilocybin's effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Nausea, vomiting and dizziness of motion sickness (prevention and treatment); Vertigo of motion sickness (injection)
Not studied with psilocybin; its marked drowsiness and dizziness may add to psilocybin's altered state and confusion.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Hay fever and upper respiratory allergy symptoms; Common cold symptoms (runny nose, sneezing)
Its drowsiness and confusion may add to psilocybin's effects, though it has no meaningful serotonin effect. Also, it raises heart rate.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Trouble falling asleep (occasional sleeplessness); Nausea and vomiting of pregnancy (with pyridoxine, Rx)
It is sedating and may cause confusion or delirium during psilocybin's altered state.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Allergy symptoms (hay fever and upper respiratory allergies); Hives (urticaria): reduces hives and relieves itching
Not studied with psilocybin; no linking mechanism is described.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Anxiety and tension; Itching from allergic skin conditions (hives, eczema, contact dermatitis)
Its sleepiness and confusion may add to psilocybin's effects. Also, it can cause heart-rhythm (QT) effects, more so with other drugs that do this.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Occasional sleeplessness associated with minor aches and pains
Its diphenhydramine causes drowsiness and may cause confusion under psilocybin. Also, regular ibuprofen use can raise blood pressure, as psilocybin briefly does.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Allergy symptoms (hay fever and other respiratory allergies); Chronic hives (chronic idiopathic urticaria), skin symptoms (Rx)
Not studied with psilocybin; no linking mechanism is described; it can cause drowsiness and fatigue.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Allergy symptoms (hay fever and upper respiratory allergies)
Not studied with psilocybin; no linking mechanism is described.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- Loratadine–pseudoephedrine · Claritin-D 12 Hour, Claritin-D 24 Hour, Alavert Allergy and Congestion D-12Evidence: No psilocybin data
Allergy symptoms (sneezing, runny nose, itchy or watery eyes, itchy nose or throat); Nasal and sinus congestion and pressure from colds or allergies
Its pseudoephedrine may raise blood pressure and heart rate, adding to psilocybin's brief rise; loratadine has no known psilocybin interaction.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Motion sickness (nausea, vomiting, dizziness); Vertigo from inner-ear (vestibular) disease (prescription)
Its sedation and confusion risk may add to psilocybin's effects.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Occasional sleeplessness associated with minor aches and pains
It causes drowsiness and may cause confusion with psilocybin; regular naproxen use can raise blood pressure, as psilocybin briefly does.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Allergic conditions (hay fever, hives, allergic eye inflammation); Severe allergic reactions (add-on to epinephrine)
Its sedating and drying (anticholinergic) effects may add drowsiness or confusion with psilocybin. Also, it may lower the seizure threshold.
CO: unsettled · OR: not mentioned in rule · NM: rules not final
- Promethazine-codeine ("lean")Evidence: No psilocybin data
Cough and upper respiratory symptoms from allergies or the common cold (adults 18+)
Not studied with psilocybin; with other sedatives, it can cause deep sedation and slowed breathing. Stopping it suddenly after regular use can cause withdrawal.
CO: unsettled · OR: not mentioned in rule · NM: rules not final
Cough and upper respiratory symptoms with allergy or the common cold
Its promethazine is sedating and drying, so it may add drowsiness or confusion with psilocybin. Its dextromethorphan may add serotonin effects.
CO: unsettled · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 17 | Sedating or CNS depressant |
| 13 | Anticholinergic |
| 4 | Raises blood pressure or heart rate |
| 3 | Lowers seizure threshold or carries seizure risk |
| 3 | Psychiatric reactions |
| 2 | Dissociative (NMDA antagonist) |
| 2 | Serotonergic |
| 1 | Blocks 5-HT2A (may blunt effects) |
| 1 | Liver injury |
| 1 | Lowers blood pressure or causes orthostasis |
| 1 | Opioid |
| 1 | QT-prolonging |
| 1 | Withdrawal or rebound if stopped abruptly |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group. 3 unsettled.
Colorado rules 2.2(A)(6) and 2.2(A)(7) both address participants taking lithium or an antipsychotic, and the rule text does not state how the two fit together. The rule names “antipsychotic medications” without defining the term or limiting it by indication, so whether it covers this medication is unsettled; the regulator has not addressed this. Promethazine is a phenothiazine, the chemical family of several antipsychotics, and blocks dopamine D2 receptors, but it is approved for allergy, nausea, motion sickness and sedation, not for psychosis. Colorado rule 2.2(A)(6) states that Facilitator licensees may not provide natural medicine services to participants taking lithium or antipsychotic medications. Under 2.2(A)(7), services may proceed only after a referral from a licensed provider (MD, DO, APN, PA or clinical facilitator), medical clearance from the participant's provider, or a consultation and risk review with a provider licensed to diagnose and treat the condition identified as a risk factor; the Facilitator documents the consultation, and where it identifies heightened risk, the rule requires a safety plan and written informed consent.
Colorado rules 2.2(A)(6) and 2.2(A)(7) both address participants taking lithium or an antipsychotic, and the rule text does not state how the two fit together. The rule names “antipsychotic medications” without defining the term or limiting it by indication, so whether it covers this medication is unsettled; the regulator has not addressed this. This syrup contains promethazine, a phenothiazine (the chemical family of several antipsychotics) that blocks dopamine D2 receptors, but promethazine is approved for allergy, nausea and sedation, not for psychosis. Colorado rule 2.2(A)(6) states that Facilitator licensees may not provide natural medicine services to participants taking lithium or antipsychotic medications. Under 2.2(A)(7), services may proceed only after a referral from a licensed provider (MD, DO, APN, PA or clinical facilitator), medical clearance from the participant's provider, or a consultation and risk review with a provider licensed to diagnose and treat the condition identified as a risk factor; the Facilitator documents the consultation, and where it identifies heightened risk, the rule requires a safety plan and written informed consent.
Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 1 of the 20 medications in this group is psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRelated classes
- Sleep medications6 shared
- Pain relievers3 shared
Records reviewed 2026-10-03 to 2026-10-14. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z